We found lower hydrolytic activities in the MG thymus compared with adult controls, accompanied by translocation of AChE-R from the cytoplasm to the membrane and increased expression of the signaling protein kinase PKC-βII. To explore possible causal association of AChE-R changes with thymic composition and function, we employed an AChE-R transgenic model and showed smaller thymic medulla compared to strain-matched controls, indicating that AChE-R overexpression interferes with thymic differentiation mechanisms. Interestingly, AChE-R transgenic mice showed increased number of CD4+CD8+ cells, that were considerably more resistant in vitro to apoptosis than normal thymocytes, suggesting possibly altered positive selection. We further analyzed microarray data of MG thymic hyperplasia compared to healthy controls and found continuous and discrete changes in AChEannotated GO categories. Together, these findings show that modified AChE gene expression and properties are causally involved in thymic function and development.
Introduction
Myasthenia Gravis (MG) is an autoimmune disorder caused by autoantibodies against the nicotinic acetylcholine receptor (nAChR) on the postsynaptic membrane at the neuromuscular junction (NMJ) and characterized by weakness and fatigability of the voluntary muscles 1 . Although the production of anti-AChR antibodies is directly attributable to B cells, there is extensive evidence that T cells have a key role in the autoantibody response 2, 3 . As the thymus is a key organ in the production and education of functional T lymphocytes, it may be implicated in the initiation and progress of MG. Moreover, approximately 75% of patients display thymic abnormalities 4 . Of these, 85% have hyperplasia (germinal-center formation) and 15%
have thymomas. Furthermore, thymectomy often results in improvement in most patients 5, 6 . Last but not least, both B and T cells from the thymus gland of myasthenic patients are more responsive to AChR than are B and T cells from peripheral blood 7 .
All these observations point to a major role of thymus in the pathogenesis of MG. The main treatment for MG is the use of anticholinesterase drugs (e.g. pyridostigmine)
that enhance the duration of acetylcholine in the synaptic cleft and thus improve the impaired neurotransmission 8, 9 .
Acetylcholinesterase (AChE), whose well-known function is to hydrolyze acetylcholine, is not a single entity but a combinatorial complex of protein products due to alternate promoter usage 10 and alternative splicing 11 giving rise to multiple AChE isoforms in a stress-dependent and tissue-specific manner 12 : the "synaptic" (S), (also called T, for "tailed" 13 ) the "erythrocytic" (E) and the "readthrough" (R)
isoforms of AChE. These isoforms share a similar catalytic domain but differ in their C-terminal domain, which influences their molecular form, localization and confers them specific features 14 . In the last decade, new non-classical and sometimes even non-cholinergic functions of AChE isoforms have been described: in neuritogenesis 15 ,
For personal use only. on September 24, 2017 . by guest www.bloodjournal.org From synaptogenesis 16 , cell adhesion 17 , osteogenesis 18 and haematopoiesis 19 . AChE-S is the main isoform in physiological conditions, but shifted splicing of AChE pre-mRNA leading to overproduction and accumulation of the normally rare AChE-R variant can occur after exposure to acute stress 8 or anticholinesterase drugs (as for Gulf War veterans) or under treatment of Alzheimer's disease 8 . As anticholinesterase drugs are used in the treatment of MG, they might modify the balance between AChE-S/AChE-R. Indeed, Brenner and colleagues detected more AChE-R in serum of human myasthenic patients and in serum and muscles of rats with experimental autoimmune MG (EAMG) 20 . AChE-R seems to have a fundamental role in the pathophysiology of MG as an antisense oligonucleotide that selectively lowers AChE-R in serum and muscle alleviates electromyographic abnormalities and restores clinical status of EAMG rats 20 . Moreover, both AChE-R and its naturally cleavable C-terminal domain showed powerful proliferative effects in blood cells 21, 22 and tight interactions through its unique C-terminal domain with the scaffold protein RACK1 and through it with protein kinase C (PKC)βII 23 or PKCε 24 .
As AChE is present in thymus 25 Biomédicale) of Bicetre Hospital, 94270 Le Kremlin Bicêtre, France. All subject groups included both female and male subjects; the adult healthy volunteers and MG patients' were 14-to 72-year-old, and newborns were 11-day-to 4-month-old.
Mice. Transgenic mice overexpressing the AChE-R variant (TgR) were obtained as described 26, 27 in an FVB/N background. Strain, gender and age-matched FVB/N mice served as controls. The Hebrew University committee approved animal procedures (NS-04-21).
RNA extraction and real-time RT-PCR. RNA was extracted using the RNeasy lipid tissue kit (Qiagen, Valencia, CA) as per manufacturer's instructions from normal and pathological thymus samples. DNase treatment was applied to avoid DNA contamination. RNA integrity was confirmed by gel electrophoresis, and RNA concentration and purity were assessed spectrophotometrically. For each sample, 0.4 µ g RNA was used for 20µl cDNA synthesis using Promega RT-PCR kit (Promega, Madison, WI). Real-time RT-PCR was performed in triplicates for each sample using ABI prism 7900HT and SYBR green master mix (Applied biosystems, Foster City,
For personal use only. on September 24, 2017 . by guest www.bloodjournal.org From CA). ROX, a passive reference dye, was used for signal normalization across the plate. Primer sequences are described in Table I and in supplemental Fig s1A. Annealing temperature was 60º C for all primers. Serial dilution of samples served to evaluate primers efficiency and the appropriate cDNA concentration that yields linear changes. Melting curve analysis and amplicons sequencing verified the end product and β -actin served as reference gene.
Microarray experiments
Four pools of thymic RNA were prepared from MG patients undergoing therapeutic thymectomy (with severe thymic hyperplasia (MH; n = 5) or mild thymic hyperplasia (ML; n =4)), adult normal controls (n = 4), and from 1-wk-to 1-year-old controls (NB; n =10) which served as a common reference. MG and control adult samples were from 16-25 years old subjects and all samples including the NB were from females. Thymuses containing more than three, or less than two germinal centers per section were defined as severe or mild hyperplasia, respectively 28 . We chose to work with pools of thymic RNA (from homogeneous categories of patients) to minimize inter-individual variations. Real time RT-PCR performed for several dysregulated genes in larger series of patients validated our results 29 , 28 . Extraction of total RNA and hybridization on Agilent arrays (G4100A, Massy, France) was performed as previously described 28 . RNA quality was assessed on an Agilent Bioanalyser (Massy, France). 20 µg of total RNA was labeled with cyanine 5 or cyanine 3 using the direct labeling protocol of Agilent (Massy, France). The arrays were scanned using a 428
Affymetrix scanner (MWG-Biotech, Courtaboeuf). Images were analyzed with GenePix pro V4.0 (Axon Instruments, Dipsi Industrie, Châtillon, France) corrected by intra-and inter-normalization steps and centered on zero by the array 28 .
Microarray analysis. The mean expression ratio of transcripts in MH, ML and adult groups were compared to NB and transformed to log base 2. Using GOdist, we Immunoblots. Thymic homogenates were separated and blotted as previously 
Measurements of apoptosis. Apoptosis was measured using staining with
Annexin/propidium iodide and TdT-mediated dUTP nick-end labeling (TUNEL) (Roche Diagnostics, Meylan, France) methods as previously described 35 . Both staining methods were visualized on a FACScalibur flow cytometer. Characterization of apoptotic cells involved simultaneous tri-color fluorescence with TUNEL, anti-CD4 and anti-CD8 labeling.
Data analysis: Two-tailed Student's t-test were employed throughout except for microarray experiments. P values < 0.05 were considered significant.
Results

Gene expression changes distinguish MG hyperplasias from healthy thymuses
We first asked whether global extreme gene expression changes could distinguish between the three groups of thymic tissue: ML and MH from MG patients and adult controls compared to NBs. The ratios are presented as cumulative distribution function (CDF) ( Figure 1A ). Adult/NB ratio increases were the least pronounced.
MH/NB ratio decreases were more pronounced than both ML/NB and adult/NB, suggesting association of changes with the severity of the observed pathologies ( Fig   1A) .
Then using both discrete and continuous statistical approaches, we detected functional categories overrepresented in the different thymic samples. Detailed results of selected enriched categories compared to the global population are given in Table II .
Full lists of changed categories are enclosed under Supplementary Material.
Generally, the continuous, more sensitive, method detected more changed GO categories than the discrete approach (Fig 1B) . Importantly, combining these two methods together revealed additional information of disease-underlying changes.
MG-associated categories were previously found to be essentially related to the immune response and, in particular, to the antigen presentation category characterized by MHC class II molecules 29,28 and will not be described in this manuscript. Among the other main changes, we could detect increases in protein modification and transport as well as signal transduction especially in ML compared to NB. Also, differences in cell differentiation appeared to be modified in both MH and ML groups. Of note, the changes were opposite, probably due to the difference in cell contents between the two groups of thymuses (Table II) .
Since hyperplasic thymuses contain high number of proliferative cells 36 , we expected to observe cell-cycle related changes. Analysis of cell-cycle associated categories showed very limited changes according to both approaches between healthy adults and patients compared to the global array population. Therefore, we searched for specific changes in GO categories related to cell cycle, comparing them to their parent terms using the continuous approach. We found significant decreases in DNA replication and chromosome cycle in MH/NB group compared to the direct GO parent, cell cycle with a change in location in the increase tail (i.e in the population medians), rather than in dispersion (Fig 1C, KW P<0 .01). We conclude that thymic hyperplasia is associated with lower DNA replication activities in the myasthenic thymus, perhaps reflecting the high differentiation and activation state of the thymic cells in the MG thymus 37, 38 .
AChE-annotated categories demonstrate significant continuous change between healthy and MG patients
AChE is associated with proliferation 21 and hyperplasic thymuses are a highly proliferative tissue 36 . Using both approaches, we seemingly related observed changes in AChE -annotated GO categories (Table II, 
MG-associated changes in AChE
To analyze the relative expression of the different isoforms of AChE in thymic hyperplasia from MG patients, we employed in parallel an antibody directed to the common region of all isoforms (N19) and another one specific to the C-terminal region of the AChE-R isoform on western blots of proteins from cytoplasmic and membrane-enriched fractions (supplementary Fig s1B and C) . Importantly, total cytoplasmic AChE increased from newborns to adults but decreased from adults to MG. AChE-R levels also decreased from adults to MG (Fig 2A) . In the membrane fraction, we observed opposite non-significant trend of decrease in adults compared to NB, but an increase in MG compared to adults for total AChE, and a parallel significant change for AChE-R (Fig 2B) . The "tailed" fraction (supplementary Fig   s1B) showed no significant difference (data not shown). We could thus postulate that the modified localization of the common AChE in MG compared to adults is partly due to the translocation of the AChE-R isoform from the cytoplasm to the membrane.
Cortical thymoma is frequently found in MG patients, and is characterized by the presence of a high number of cortical thymocytes 39 . To explore the possibility that changes in AChE levels and/or properties are involved in thymopoiesis, real-time RT-PCR analyses were performed on cortical thymomas compared to healthy controls or MG hyperplasia. Results in Figure 2C indicate a moderate increase in AChE-R in thymoma patients with MG as compared to the common AChE (p=0.06) and a slight increase in AChE-R as compared to AChE in hyperplasia patients compared to healthy controls. No change was seen between the two variants in hyperplasia patients and healthy adults (Fig 2C) , likely indicating that the changes observed at the protein level reflect post-transcriptional regulation. Interestingly, in MG thymoma, the AChE-S variant was reduced, suggesting a possible role for this isoform in thymocyte apoptosis.
Catalytically inactive AChE in MG
Next we measured acetylthiocholine (AThCh) hydrolytic activity in fractionated thymic homogenates (Fig 3A) , using Iso-OMPA to selectively suppress butyrylcholinesterase activity. In MG patients, total AChE hydrolytic activities were decreased compared to NB and non-myasthenic adults (Fig 3A1) . The cytoplasmatic fraction showed reduced activity in MG patients and healthy adults as compared with newborns, but no changes were visible between MG patients and healthy adults ( Fig   3A,2) . In comparison decrease in AChE activity in MG patients compared to adults was significant both in fractions enriched with membrane-associated and "tailed" AChE ( Fig 3A,3,4) . Cumulative analysis highlighted the differences in these changes, with conspicuous decreases in adult cytoplasmatic AChE and MG-associated decreases in the "tailed" enzyme fraction (Fig 3B) . The decreased AChE activity could be attributed to the use of Mestinon, a reversible AChE inhibitor used in the treatment of the MG patients included in the study.
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Altogether with the western blot analysis, these results support the notion that membrane-associated AChE and AChE-R, devoid of catalytic activity accumulates in the myasthenic thymus. We thus investigated the potential new non-cholinergic pathways that could be implicated.
Involvement of the PKC pathway
The AChE-R monomers can selectively interact with, and elevate the amounts of the scaffold protein RACK1 and protein kinase C (PKC) 23, 40 , which induces its mobilization into the plasma membrane 23 . We thus analyzed the parallel expression of the RACK1 and PKCβII proteins in the different subcellular fractions.
Immunolabeling of PKCβII showed significant increases in the cytoplasmatic (p<0.001) and tailed fractions (p< 0.001) but not membrane-associated PKCβII labeling from adults to MG patients, indicating that PKCβII is overexpressed in MG thymuses and translocates to the tightly membrane associated fraction including the tailed AChE (Fig 4A) .
RACK1 showed parallel increases from adults to MG patients in the cytoplasmatic fraction but no change in the membrane-associated (Fig 4B) and in tailed fraction (data no shown). Mild cytoplasmatic increases in MG patients RACK1 as compared to healthy adults were accompanied by no changes in the membrane-associated fraction (Fig 4B) , suggesting that the translocation of AChE-R to the membrane occurred independently from RACK1.
Altogether, these analyses demonstrated altered expression pattern of AChE-R associated with translocation of PKC to the membrane. To analyze whether these changes could be causally involved in the thymic pathologies, we studied the thymus of mice overexpressing the AChE-R variant.
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Thymopoietic effects of AChE-R splice variant
TgR mice overexpressing AChE-R served to test the influence of AChE-R on thymic differentiation and proliferation. Medullary areas were considerably smaller in TgR compared to strain-matched FVB/N controls (Fig 5A) , supporting the notion that overexpressed AChE-R may influence thymocyte differentiation. Thymic weight, in contrast was significantly increased in TgR mice (Fig 5B) . TgR thymuses further contained significantly more thymocytes than FVB/N controls (Fig 5C) . Specifically, thymuses from TgR mice included less CD3-high thymocytes, compared to FVB/N controls, indicating a deficit in thymocyte maturation (Fig 5D) . Staining with anti-CD4 and anti-CD8 antibodies served to define the major thymic subsets according to their differentiation state (Fig. 5E-J) . In TgR mice, the absolute number of the doublepositive (DP) subset was two-fold increased compared to FVB/N controls (75 ± 13 10 6 and 32.7 ± 4.3x10 6 , respectively p<0.05) (Fig 5E) . The relative analysis of the thymic subpopulations indicates that CD8+ subset remained unchanged while CD4+ subset was reduced in AChE-R overexpressing thymuses (Fig 5I-J) , counterbalanced by an increase in the percentage of CD4+CD8+ cells (Fig 5H) .
Overexpression of this particular AChE-R variant thus disturbes thymus organization and leads to a pronounced increase in DP thymocyte number and a decrease in the number of mature CD3-high cells, expressing essentially the CD4 marker.
Transgenic excess of AChE-R elevates thymic PKC levels
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To test whether excess thymic AChE-R spontaneously loses its catalytic activity, we compared AChE activities with its immuno-labeling in thymuses of TgR mice and in strain-matched FVB/N controls.
In the thymus, immunoblot analysis showed two bands of 70 and 60 kDa for the FVB/N mouse, a prominent overproduction of a 55 kDa hAChE-R band in TgR mice (Fig 6A) . In parallel to the AChE-R increase, TgR mice showed PKC and RACK1 overexpression (Fig 6A) . Thymic homogenates from TgR mice further showed a 2-fold increase in hydrolytic AChE activity (Fig 6B1) (p< 0.01) . TgR thymic increases were predictably observed in the cytoplasmic (p<0.003) and membrane-associated (p=0.06) (Fig 6B2,3) but not the tailed fraction (Fig 6B4) . We conclude that transgenic excess of AChE-R accumulation does not by itself imply decrease in its activity, and that active AChE-R excess, does induce PKC and RACK1 elevation in the thymus.
Apoptosis differences in AChE-R transgenic thymuses
Since total numbers of thymocytes were increased in AChE-R transgenic mice, we wondered whether the overexpression of this variant could influence the apoptosis of thymocytes. Live thymocyte counts were compared to those of Annexin+ and TUNEL+ cells following 1 or 2 days in culture. As shown in Figure 7 A-B, thymocytes grown from TgR mice were less sensitive to spontaneous apoptosis than controls. Costaining with CD4/CD8 showed that TgR double-positive thymocytes, in particular, were less sensitive to apoptosis (Fig 7C) than CD4+ or CD8+ cells (Fig   7D-E) . This could explain the previously observed abundance of double-positive cells in TgR thymuses and the lower percentage of CD4+ cells in those thymuses (Fig 5H- 
J).
Discussion
Using a plethora of molecular biology, biochemistry and transgenic engineering techniques, we explored the putative association of altered AChE gene expression with the thymic pathologies characteristic of MG. First, large-scale microarray analysis showed a general decrease in gene expression of the adult healthy thymus, but increase in patients with MG-induced thymic hyperplasia. Importantly, we also found changes in GO categories to which AChE is annotated between healthy and both types of tested patients displaying different degrees of hyperplasia (MH and ML). Although AChE is annotated to both BP and MF GO categories, significant changes occurred only in AChE-annotated BP categories, indicating that AChE affects global, rather than specific, molecular mechanisms both in MG thymic hyperplasia and in healthy adults compared to newborns. We further found additional GO categories that may be involved in thymic pathology, such as cell and lymphocyte differentiation, which is compatible with the cytological changes observed in the MG thymus pathologies 41 .
AChE-R promotes proliferation and/or protects thymocytes from apoptosis
Previous research described distinct roles for specific AChE isoforms in cell proliferation and apoptosis, both in brain and blood 40, 42 . Thus, AChE-S and AChE-Sin both suppressed progenitor proliferation in neocortical development of transgenic mice 42 whereas AChE-R, and its cleavable C-terminal peptide ARP, both promote proliferation of CD34+ blood cell progenitors 21, 43 . On the other hand, AChE-S was reported to induce apoptosis 44, 45 through facilitating apoptosome formation.
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In MG disease, the thymus is the site of cell activation and high proliferation 46 .
Interestingly, in the MG thymus, AChE-R was found to be increased in the membrane fraction, but not in the cytoplasm, indicating that AChE-R is translocated to the membrane-associated fraction. This phenomenon could reflect the activation state of the thymic cells, as it was observed in hippocampal neurons under stress 23 . Most of the MG AChE protein was hydrolytically inactive, compatible with findings of others who noted that much of the nascent AChE molecules remain inactive 47 . Together with data showing AChE-R increase in the serum of MG patients 20 , these results suggested the influence of AChE-R in MG thymic pathology.
To challenge this hypothesis, we analyzed the thymus of TgR mice compared to that of strain-matched FVB/N controls. We found an increase in both AChE immunolabeling and hydrolytic activity, suggesting that AChE inactivation in MG is not caused by its overexpression; however, the increase in PKC immunolabeling, in TgR mice, indicated that the AChE-R variant induces PKC-βII elevation in the thymus. Similarly to thymus from MG patients, the thymus from TgR mice displays an abnormally high number of thymocytes compared to control mice. Interestingly, this increased number was not due to an increased number of mature cells, but rather to increased DP immature T cells. These results are compatible with a previously published report showing that AChE-R promotes the proliferation of progenitor cells 21 . This could also be explained by a role of the overexpressed PKCβII in the TgR DP cells, since PKCβII was shown to play a role BCR survival signaling 48 Alternatively, AChE-R could protect DP thymocytes from apoptosis, by maintaining a high level of Bcl2 for example. Indeed there is a relationship between AChE and Bcl-2 49 .
To explain the high number of thymocytes in the AChE-R mice, we propose three non-mutually exclusive hypotheses: 1) AChE-R could be produced by cortical stromal cells and exert a protective signal from apoptosis to the neighboring thymocytes. It is well established that the cortical epithelium is the major player of the positive selection and that DP cells located in the cortex require signals in contact with the cortical epithelium to survive [50] [51] [52] . Therefore, the positive selection process could be more efficient in TgR mice than in normal mice; 2) AChE-R could be produced by the thymocytes themselves. Our data showing that thymocytes from AChE-R mice cultured in vitro are more resistant to apoptosis than normal thymocytes, even in the absence of stromal cells are in favor of this hypothesis. 3) Another possibility is that the cholinergic signals and AChE's catalytic activity influence thymocytic apoptosis, but this effect is counterbalanced by a proliferative effect that could be predominant for the AChE-R form and the ARP peptide. This hypothesis is likely since we found more proliferating cells (expressing the Ki67 antigen) in the thymus of AChE-R transgenic mice compared to control mice (data not shown).
Unique translocation of AChE-R to the membrane in the MG thymus
At the protein level, MG thymuses showed overexpressed AChE-R with reduced hydrolytic activity, which translocated from the cytoplasm to the membrane along 
AChE-R changes during thymus aging
The multileveled increase in gene expression in thymic hyperplasia reflects opposite effects to those observed during thymic development. In both humans and rats, the aging thymus undergoes programmed deterioration correlated with increased thymic AChE expression 25 , in accordance with our results with the common anti-AChE antibodies. Previous research showed an age-related increase in serum AChE 58 . Our data show significantly decreased AChE-R expression in adults as compared to newborns in both the cytoplasmatic and membrane-associated thymic fractions, suggesting causal involvement of AChE-R in thymus development and aging. AChE-R can thus be viewed as an indicator of thymic status, decreased in degenerativeaging thymus but overexpressed in membrane cell fractions of hyperplasicmyasthenic thymus.
For personal use only. on September 24, 2017 . by guest www.bloodjournal.org From Together, our research sheds new light on the thymic role in MG, demonstrates the existence of membranal, albeit catalytically inactive AChE-R in the MG thymus and suggests that this variant induces active thymopoiesis, and reduces apoptosis. To date, most of the pharmacological approaches to MG are aimed at AChE inhibition and anti-inflammation 59 . However, AChE inhibitors notably induce the accumulation of AChE-R 8, 60 . This could reduce ACh levels, inhibiting the cholinergic capacity to limit the production of pro-inflammatory cytokines 61 . In addition, AChE-R increases the proliferation rate of hematopoietic cells 22 due to its non-catalytic function(s). This, in turn may facilitate the progression of thymic hyperplasia and/or thymoma. To avoid this therapy-induced pathology, one might select the antisense approach 20 , selectively destroying the AChE-R mRNA variant and thus limiting its proliferative effects. 
